Welcome back to the third blog on US COVID-19 vaccines. Since October, two sponsors, Moderna and BioN/Pfizer, have filed for Emergency Use Authorization (EUA) in the US, the latter was approved in the UK. Though more is now known about the efficacy, which looks great so far (see chart), more will be known about short-term side effects over the next two weeks as review meetings are set to take place Dec. 10th and 17th. Data results for the three remaining agents, sponsored by Astra Zeneca,...

Last month, I reported on 4 U.S. phase 3 vaccines in development which was spurred due to the release of clinical trial protocols to the public. Although no new protocols have been released, events have occurred since then that may impact the trajectory of the vaccines that launch into the market, which are discussed below.

This month’s chart adds two more phase 3 candidates. One is Novavax’s Nvx-Cov2373 vaccine. What makes this unique is that it is being tested in conjunction with a flu...

Having worked in the pharmaceutical industry since the mid-90’s, I'm often asked my opinion on the Covid-19 vaccines. such as "will you get vaccinated as soon as one is available?" and "when will that be?" Having paid little attention to the details of the myriad contenders in various stages of development, my lazy answer has been, "I’ll let you know when I see data results".

Then I learned that phase 3 protocols were released to the public when Dr. Fauci spoke last week to Governor Murphy...

Last month, I created an LLC in New Jersey. My accountant was kind enough to offer to set this up for me, but after asking around, it seemed simple to do, so I gave it a shot. There were some steps where I had to 'dial a friend,' my accountant, and the N.J. small business hot line. Here is the process I went through, along with some tips and estimated timelines. If you are thinking of setting up an LLC, read this blog post first, and then let me know if it was helpful once you complete the...